Cengild Medical Berhad (KLSE:CENGILD)
Malaysia · Delayed Price · Currency is MYR 0.1950
0.00 (0.00%)
At close: Sep 2, 2026
Cengild Medical Berhad Ratios and Metrics
Market cap in millions MYR. Fiscal year is July - June.
Millions MYR. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 162 | 162 | 192 | 262 | 329 | 328 | |
Market Cap Growth | -18.75% | -15.22% | -26.98% | -20.25% | 0.45% | - |
Enterprise Value | 201 | 194 | 138 | 188 | 255 | 331 |
Last Close Price | 0.20 | 0.20 | 0.22 | 0.30 | 0.36 | 0.36 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 14.23 | 14.20 | 17.33 | 23.68 | 24.76 | 34.88 |
Forward PE | - | 23.00 | 23.00 | 23.00 | 23.00 | 24.24 |
PS Ratio | 2.22 | 2.22 | 2.40 | 3.93 | 4.68 | 5.08 |
PB Ratio | 1.35 | 1.35 | 1.67 | 2.36 | 3.10 | 3.52 |
P/TBV Ratio | 1.35 | 1.35 | 1.67 | 2.36 | 3.10 | 3.52 |
P/FCF Ratio | - | - | - | - | 27.92 | 21.98 |
P/OCF Ratio | 12.39 | 12.40 | 11.91 | 20.28 | 23.65 | 21.37 |
PEG Ratio | - | 0.64 | 0.64 | 0.64 | 0.64 | 0.67 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EV/Sales Ratio | 2.74 | 2.64 | 1.72 | 2.82 | 3.62 | 5.14 |
EV/EBITDA Ratio | 10.13 | 10.54 | 7.10 | 11.94 | 15.59 | 22.72 |
EV/EBIT Ratio | 14.11 | 14.30 | 9.60 | 14.24 | 17.60 | 28.61 |
EV/FCF Ratio | - | - | - | - | 21.60 | 22.21 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Debt / Equity Ratio | 0.72 | 0.72 | 0.42 | 0.07 | 0.14 | 0.17 |
Debt / EBITDA Ratio | 4.49 | 4.49 | 2.28 | 0.47 | 0.85 | 1.01 |
Debt / FCF Ratio | - | - | - | - | 1.27 | 1.09 |
Net Debt / Equity Ratio | 0.32 | 0.32 | -0.33 | -0.74 | -0.79 | -0.76 |
Net Debt / EBITDA Ratio | 2.09 | 2.09 | -1.94 | -5.22 | -5.15 | -4.87 |
Net Debt / FCF Ratio | -0.56 | -0.56 | 1.78 | 29.40 | -7.14 | -4.76 |
Asset Turnover | 0.36 | 0.36 | 0.51 | 0.51 | 0.56 | 0.78 |
Inventory Turnover | 16.55 | 16.55 | 22.93 | 23.09 | 31.23 | 36.62 |
Quick Ratio | 3.05 | 3.05 | 4.78 | 6.59 | 9.17 | 7.91 |
Current Ratio | 3.18 | 3.18 | 4.91 | 6.73 | 9.32 | 8.04 |
Return on Equity (ROE) | 9.76% | 9.76% | 12.02% | 11.01% | 13.35% | 17.60% |
Return on Assets (ROA) | 4.18% | 4.18% | 5.72% | 6.25% | 7.19% | 8.74% |
Return on Invested Capital (ROIC) | 7.22% | 9.38% | 20.41% | 37.02% | 50.17% | 33.82% |
Return on Capital Employed (ROCE) | 6.60% | 6.60% | 8.90% | 11.20% | 12.00% | 10.70% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Earnings Yield | 7.04% | 7.04% | 5.77% | 4.22% | 4.04% | 2.87% |
FCF Yield | -42.02% | -42.02% | -11.06% | -1.07% | 3.58% | 4.55% |
Dividend Yield | 1.85% | 1.85% | 4.35% | 2.51% | 2.04% | 1.03% |
Payout Ratio | 26.28% | 50.96% | 73.07% | 55.64% | 45.60% | - |
Buyback Yield / Dilution | - | 0.00% | 0.11% | -1.00% | -27.94% | -7.56% |
Total Shareholder Return | 1.80% | 1.85% | 4.46% | 1.51% | -25.90% | -6.53% |